|
Back to Index
The
Plight of women who become pregnant during clinical trials in Zimbabwe
Joshua
Chigodora, Southern Africa HIV and Aids Information Dissemination
Service (SAfAIDS)
April
19, 2006
Dambudzo is
a domestic worker in one of Harare's northern suburbs. Like most
domestic workers in the country, her monthly wage is approximately
US$13. After falling ill on and off since 1994, she decided to go
for HIV testing in January 2006. The result came up positive. Upon
learning of the result, her husband Karikoga (a gardener at Dambudzo's
workplace) also decided to get tested, and he also tested positive.
Now that both husband and wife knew their HIV status, the question
they asked was "what's next"? With their meagre wages, they cannot
afford to buy ARVs even under the government rollout programme.
The pair visited
one of the New Start Centres in the city (New Start Centres are
voluntary counselling and testing centres supported by Population
Services International). After receiving intensive counselling,
the two were referred to one of the clinical research trial centres
operating in Harare. The wife was enrolled at a different site than
the husband.
The couple thought
this was the end of their dilemma, but it was only the beginning
of worse things to come for Dambudzo. Dambudzo went through all
the pre-qualification tests, and signed the informed consent form.
On returning two weeks later to start on the research programme,
she had to undergo further tests, which included a pregnancy test.
To her dismay, Dambudzo discovered she was pregnant, and that, this
made her ineligible for the research programme according to the
consent form that she signed. The officials simply told her that
fact and sent her home.
Karigoga had
no such problems, he is already on the programme.
While research
may lead to effective treatments, programmes funded by western donors
should not exploit local populations. National and international
ethical principles and guidelines have been developed and are available
in Zimbabwe. However, it is not clear what actually happens with
the implementation of these guidelines in real situations. Dambudzo's
case highlights the need to take context into account when defining
principles for the protection of human subjects.
Officials at
the clinical trials centre argue that they cannot be blamed for
what is a clear violation of the conditions under which Dambudzo
joined the research programme, but here we have a woman, poor, half
literate, pregnant, HIV positive with a CD4 count of 27 and nowhere
to turn to. The woman is just told come back after giving birth
and thanks very much!!!
Yes Dambudzo
should not have violated the rules, but did she even understand
them? When talking to her one gets the feeling that she thought
she was getting into a treatment programme rather than a clinical
trial. It is clear from what she told me that she does not understand
the goals of the research.
I doubt very
much that the researchers under this project considered whether
participants knew the meaning of informed consent and the problems
that might arise in resource limited settings such as the case in
Zimbabwe. Informed consent is essential in conducting clinical trials,
however, there are so many obstacles in its application in real
situations. For example, language problems and the lack of familiarity
with technical terminology and concepts limits participants' understanding
of the issues and the possible risks they are likely to be exposed
to. Moreover most of them are desperate to have access to life saving
treatment. How likely are they to refuse the conditions imposed?
The consent
forms used in the research project are long and written in legal
jargon. I doubt very much if all the participants read all the text,
less still understand any of it. I doubt if even the researchers
bothered to go through the document with the participants.
According
to South African government guidelines: "If a patient withdraws
from a study for any reason, or where a study is completed, they
should be advised about the ongoing management of their condition.
Except in cases where therapeutic efficacy is demonstrated, ongoing
therapy should be according to the local standard of care. Costs
of this care should be borne by the local health service, the patient's
medical insurance or the patient themselves.
Many patients
who participate in HIV/AIDS treatment trials have no alternative
access to drug therapy. Where a patient has a therapeutic response
to a study drug, that patient should be offered ongoing treatment.
In designing studies, consideration should be given to the costs
of long term provision of study drugs and of clinical monitoring,
including the costs of medical staff. The duration of drug therapy
in a study should be clearly stated in the patient information section
of the informed consent document."
It is important
to address the issue of post trial care during the inception stages
of a clinical trial programme, yet the consent form used under this
programme actually states the research programme is under no obligation
to provide such care.
I make an appeal
to the researchers to re-examine their approach based on the fact
that the subjects they are dealing with are human beings, not animals.
The sacrifices they made, albeit unknowingly, should be valued and
treasured as this contributes to the betterment of those infected
and affected and to human health in general.
Dambudzo needs
assistance, and assistance now!!! I call upon the funders of this
research, civil society, associations of people living with HIV
and AIDS and the government to intervene and make her life meaningful.
Four questions
immediately come to mind:
- Are we not
seeing a case of discrimination on the basis of gender?
- Doesn't the
research centre have a moral and ethical obligation to provide
support services in the event of such an eventuality?
- What are
the human right and ethical issues here?
- Why was she
not referred to an MTCT programme?
Dambudzo and
Karikoga's case may seem like an isolated incident, however, this
could be just a tip of the iceberg. The couple's plight only came
to light because they chanced upon someone who cares and who is
knowledgeable about people's rights. How about the hundreds of poor
people out there who are desperate for treatment, but have no idea
what they are entitled to when joining clinical research programmes.
Visit the SAfAIDS
fact sheet
Please credit www.kubatana.net if you make use of material from this website.
This work is licensed under a Creative Commons License unless stated otherwise.
TOP
|